EUVIMEDEUVIMED entdecken
Crossref

Musculoskeletal disease in acromegaly—a population-based registry study

Christian Rosendal iD, Mai Christiansen Arlien-Søborg, Eigil Husted Nielsen, Claus Larsen Feltoft, Åse Krogh Rasmussen, Marianne Skovsager Andersen, Jens Otto Lunde Jørgensen, Jakob Dal

European Journal of Endocrinology · 03.03.2025 · 192 (3) · 308-317

DOI: 10.1093/ejendo/lvaf047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, online erschienen am 13.03.2025. Verfasst von Christian Rosendal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Aalborg University Hospital, 9000 Aalborg, Denmark. Hauptthemen laut MEDLINE: Acromegaly, Musculoskeletal Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Pfizer, Ipsen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Acromegaly is associated with multiple musculoskeletal complications that affect the quality of life and work ability. We aimed to examine the risk of osteoarthritis, musculoskeletal surgery (including joint replacement), osteoporosis, fractures, and analgesic consumption in Danish acromegaly patients.

Design

National, registry-based cohort study.

Methods

All validated incidents and prevalent cases of acromegaly in the period 1977-2021 (n = 844) were included and matched 1:100 with healthy controls. Outcomes were identified using diagnosis, surgical procedure, and medication codes and analyzed using Cox regression and Kaplan-Meier plots.

Results

Patients were at significantly increased risk of osteoarthritis of the shoulder [hazard ratio (HR): 5.25 (3.05; 9.06)], hip [HR: 3.15 (2.57; 3.87)], and knee [HR: 2.25 (1.85; 2.72)], and medically treated osteoporosis [HR: 2.13 (1.64; 2.78)] even before acromegaly diagnosis. The risk of joint replacement surgery of the shoulder [HR: 4.60 (2.57; 8.25)], hip [HR: 3.32 (2.67; 4.12)], and knee [HR: 2.52 (1.89; 3.36)] was increased in acromegaly patients, as was the risk of being prescribed weak analgesics [HR: 1.22 (1.04; 1.44)] or opioids [HR: 1.58 (1.38; 1.82)]. Surgical complications [HR: 2.19 (1.59; 3.03)] and repeat hip surgery [HR: 3.64 (2.09; 6.34)] also exhibited increased risk in patients.

Conclusion

In acromegaly, severe osteoarthritis involving multiple joints develops even before acromegaly diagnosis and continues to progress over time after acromegaly treatment. Furthermore, acromegaly imposes an increased risk of medically treated osteoporosis, musculoskeletal surgery—particularly joint replacement surgery—, surgical complications, and the necessity of analgesic medication. Our findings warrant further research into the management of musculoskeletal disease in acromegaly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcromegalyMusculoskeletal DiseasesHumansMaleFemaleRegistriesMiddle AgedDenmarkAdultAgedCohort StudiesOsteoporosisOsteoarthritisRisk Factors

Stichwörter der Autor:innen

acromegalyjoint replacement surgerymusculoskeletal diseaseosteoarthritisosteoporosis

Autor:innen und Institutionen

  • Department of Endocrinology, Aalborg University Hospital, 9000 Aalborg, Denmark.
  • Department of Endocrinology and Internal Medicine, Aarhus University Hospital, 8200 Aarhus, Denmark.
  • Department of Medicine, Copenhagen University Hospital-Herlev and Gentofte Hospital, 2730 Herlev, Denmark.
  • Department of Nephrology and Endocrinology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
  • Department of Endocrinology, Odense University Hospital, 5000 Odense, Denmark.
  • Department of Endocrinology, Aalborg University Hospital, Steno Diabetes Center North Jutland, 9260 Aalborg, Denmark.

ORCID-Profile: Christian Rosendal

Förderung

  • Pfizer
  • Ipsen

Zitieren

APA

Rosendal, C., Arlien-Søborg, M. C., Nielsen, E. H., Feltoft, C. L., Rasmussen, Å. K., Andersen, M. S., Jørgensen, J. O. L., & Dal, J. (2025). Musculoskeletal disease in acromegaly—a population-based registry study. European Journal of Endocrinology, 192(3), 308-317. https://doi.org/10.1093/ejendo/lvaf047

Vancouver

Rosendal C, Arlien-Søborg MC, Nielsen EH, Feltoft CL, Rasmussen ÅK, Andersen MS, et al. Musculoskeletal disease in acromegaly—a population-based registry study. European Journal of Endocrinology. 2025;192(3):308-317. doi:10.1093/ejendo/lvaf047

BibTeX
@article{Rosendal2025,
  author = {Rosendal, Christian and Arlien-Søborg, Mai Christiansen and Nielsen, Eigil Husted and Feltoft, Claus Larsen and Rasmussen, Åse Krogh and Andersen, Marianne Skovsager and Jørgensen, Jens Otto Lunde and Dal, Jakob},
  title = {Musculoskeletal disease in acromegaly—a population-based registry study},
  journal = {European Journal of Endocrinology},
  year = {2025},
  volume = {192},
  number = {3},
  pages = {308--317},
  doi = {10.1093/ejendo/lvaf047}
}
Kostenlos starten →